Video

Q&A With Samir Kapadia From Cleveland Clinic: TAVR Gives Patients New Chance at Life in Later Years

Author(s):

A whole new segment of the population, particularly elderly patients are now eligible for a lifesaving cardiac procedure with the development of Transcatheter Aortic Valve Replacement or TAVR.

A whole new segment of the population, particularly elderly patients are now eligible for a lifesaving cardiac procedure with the development of Transcatheter Aortic Valve Replacement or TAVR.

Samir Kapadia, MD, from Cleveland Clinic discussed how this procedure was developed and implemented at the Ohio institution during an interview with MD Magazine.

Now that TAVR is a surgical option patients who might otherwise have survived can now see their lives extended many years.

While TAVR may not be available at all hospitals across the country there are many institutions performing this lifesaving procedure.

While many patients can benefit from undergoing the TAVR procedure, their ability to afford the procedure and whether their insurance will cover it is another issue. As the procedure becomes more common that could help more patients get the financial help they need.

Related Videos
Experts' Perspectives: Top Stories in Cardiology for 2024
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Matthew Weir, MD: Prioritizing Cardiovascular Risk in Chronic Kidney Disease | Image Credit: University of Maryland
© 2024 MJH Life Sciences

All rights reserved.